The European consortium is seeking an innovative technology capable of treating hospital wastewater on site.

Navarrabiomed hosted the first national information event of the European THERESA PCP project on January 8, aimed at identifying a specific technology for the on-site treatment of hospital wastewater. Nearly 80 professionals attended the session, both online and in person, to learn about the key aspects of the Preliminary Market Consultation (PMC), which opened on December 22 and will run until February 28 as part of the search for solutions to this technological challenge.
The event, organized by Navarrabiomed–Miguel Servet Foundation, Fundación Progreso y Salud, and the Hospital Consortium of Vic, marked the first national information session of the project. Similar events are scheduled to take place in Estonia, Poland, the Netherlands, and Belgium in the coming weeks to further promote the initiative across Europe.

During the session, the THERESA PCP team provided an overview of the Preliminary Market Consultation process, encouraging companies to submit early-stage ideas and solutions that could pave the way for future procurement opportunities. María Bezunartea, Managing Director of Navarrabiomed-Miguel Servet Foundation, highlighted the significance of the event: “The session enabled us to better understand the functional needs involved and the importance of solutions that are modular, robust, and capable of treating multiple contaminants. In addition, participating companies demonstrated a range of approaches and collaboration opportunities, helping to strengthen the formation of consortia to address this technological challenge.”

Learn More About THERESA PCP

The THERESA PCP project has a total budget of €5,287,206, funded by the European Commission. Its objective is to identify and develop a technology for the on-site treatment of hospital wastewater through a public procurement procedure known as Innovation Procurement. This procurement model encourages private-sector companies to develop innovative technological solutions to needs for which no satisfactory solution currently exists.

At the national level, Navarre is leading this initiative through a multidisciplinary team composed of healthcare professionals from the Microbiology Service, management staff from the Administrative and General Services Directorate of the University Hospital of Navarre, as well as members of the Innovation Unit of the Department of Health and the Management Unit of Navarrabiomed–Miguel Servet Foundation.
The project also benefits from the collaboration of the Innovation Public Procurement Section of the Department of University, Innovation and Digital Transformation of the Government of Navarre.